Neuroscience research has dramatically advanced our understanding of neurodiversity's mechanisms, informing better treatments and reducing stigma.
Key Brain Structures in Neurodiversity
Modern neuroimaging has identified consistent patterns in neurodiversity:
- Amygdala: Threat processing center shows altered activation patterns in neurodiversity
- Prefrontal Cortex: Top-down emotional regulation — often underactive in neurodiversity
- Anterior Cingulate Cortex: Conflict monitoring and pain processing — implicated in neurodiversity
- Hippocampus: Memory and context; chronic stress in neurodiversity can affect its volume
- Default Mode Network: Rumination and self-referential thinking network — often overactive in neurodiversity
Neurochemistry of Neurodiversity
While the 'chemical imbalance' model is oversimplified, neurotransmitter systems play real roles in neurodiversity:
- Serotonin regulates mood, appetite, and sleep — all affected in neurodiversity
- Dopamine drives motivation and reward — disrupted in many neurodiversity presentations
- GABA and glutamate modulate excitation/inhibition balance relevant to neurodiversity
What Neuroscience Means for Neurodiversity Treatment
Neuroscience validates that neurodiversity is a brain condition, not a character failing. It points toward treatments that target specific mechanisms — and shows that both therapy and medication physically change the brain.